DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G.
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.
N Engl J Med 2000; 342: 145-153
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.